Cash Flow - Neumora Therapeutics, Inc. (NMRA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -206.44 | -182.94 | -163.28 | -114.90 | -75.42 | -26.76 | -26.76 |
| Cash flow from investing | 168.52 | -70.56 | 64.39 | -168.01 | -0.82 | -11.24 | -11.24 |
| Cash flow from financing | 77.09 | 21.60 | 231.94 | 115.74 | 293.51 | 230.10 | 230.10 |
| Change in cash | 39.17 | -231.89 | 133.05 | -167.17 | 217.27 | 192.10 | 192.10 |
Show Quarterly Cash Flow
Cash Flow - Neumora Therapeutics, Inc. (NMRA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -46.40 | -47.96 | -46.63 | -52.40 | -59.45 | -50.34 | -33.48 | -56.16 | -42.96 | -51.44 | -47.77 | -31.02 | -33.04 | -30.37 | -25.76 | -26.58 | -32.19 | -29.35 | -17.26 | -13.57 | -15.24 | -16.51 |
| Cash flow from investing | 0.07 | 42.65 | 51.32 | 30.40 | 44.16 | -98.80 | 156.99 | 21.26 | -150.00 | 13.68 | 23.82 | 24.08 | 2.82 | -8.03 | 16.69 | -91.07 | -85.61 | -0.19 | -0.55 | -0.11 | 0.03 | -0.31 |
| Cash flow from financing | 10.88 | 58.77 | -0.14 | 18.46 | 0.00 | 15.57 | 1.53 | 2.65 | 1.85 | -0.48 | 232.02 | 0.29 | 0.10 | 26.83 | 87.18 | 2.08 | -0.35 | -0.36 | 291.99 | 0.64 | 1.24 | 11.80 |
| Change in cash | -35.46 | 53.46 | 4.55 | -3.55 | -15.29 | -133.57 | 125.04 | -32.25 | -191.11 | -38.25 | 208.07 | -6.65 | -30.12 | -11.56 | 78.11 | -115.57 | -118.14 | -29.90 | 274.18 | -13.04 | -13.98 | -5.02 |